Pharmaceuticals
GSK abandons sale of older drugs portfolio
05 Dec 2014
GlaxoSmithKline's $1.57-bn restructuring to hit US jobs
04 Dec 2014
GSK is struggling with declining sales, especially in the US, mainly due to a fall in its respiratory business, which accounted for 30 per cent of its global sales last year
Ebola virus gives birth to a new vaccine
28 Nov 2014
Over the long term, GlaxoSmithKline's new vaccine is intended to protect against all Ebola outbreaks, and the drug maker hopes to produce one million doses a month of the vaccine by the end of 2015
.webp)
